Paul Bisaro
Insider Reports History
- Location
- Parsippany, NJ
- Signature
- /s/ Mark Tyndall, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Paul Bisaro:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. | Director | Common Stock | 25,862 | $3,223,698 | $124.65 | 19 Feb 2026 | Direct |
| Keenova Therapeutics plc | Director | Ordinary Shares | 4,178 | $370,798 | $88.75 | 01 Jan 2026 | Direct |
| MYRIAD GENETICS INC | Director | Common Stock | 89,941 | $362,462 | $4.03 | 05 Jun 2025 | Direct |
| TherapeuticsMD, Inc. | Director | Restricted Stock Units | 5,000 | $18,191 | $3.64 | 29 Sep 2022 | Direct |
| Zoetis Inc. | Director | Restricted Stock Unit | 0 | $0 | $124.65 | 19 Feb 2026 | Direct |
| Keenova Therapeutics plc | Director | Restricted Stock Units | 47,225 | 23 Feb 2026 | Direct |